These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8617181

  • 41. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
    Lhatoo SD, Wong IC, Polizzi G, Sander JW.
    Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
    [Abstract] [Full Text] [Related]

  • 42. A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy.
    Crawford P, Brown S, Kerr M, Parke Davis Clinical Trials Group.
    Seizure; 2001 Mar; 10(2):107-15. PubMed ID: 11407953
    [Abstract] [Full Text] [Related]

  • 43. Movement disorders associated with the use of gabapentin.
    Reeves AL, So EL, Sharbrough FW, Krahn LE.
    Epilepsia; 1996 Oct; 37(10):988-90. PubMed ID: 8822698
    [Abstract] [Full Text] [Related]

  • 44. [Gabapentin--a new antiepileptic agent].
    Nakken KO, Rytter E, Johannessen SI.
    Tidsskr Nor Laegeforen; 1998 Feb 28; 118(6):872-4. PubMed ID: 9543799
    [Abstract] [Full Text] [Related]

  • 45. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.
    McLean MJ, Morrell MJ, Willmore LJ, Privitera MD, Faught RE, Holmes GL, Magnus-Miller L, Bernstein P, Rose-Legatt A.
    Epilepsia; 1999 Jul 28; 40(7):965-72. PubMed ID: 10403221
    [Abstract] [Full Text] [Related]

  • 46. Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study.
    Mayer T, Schütte W, Wolf P, Elger CE.
    Acta Neurol Scand; 1999 Jan 28; 99(1):1-7. PubMed ID: 9925232
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Stuttering caused by gabapentin.
    Nissani M, Sanchez EA.
    Ann Intern Med; 1997 Mar 01; 126(5):410. PubMed ID: 9054293
    [No Abstract] [Full Text] [Related]

  • 49. Aggravation of focal epileptic seizures by antiepileptic drugs.
    Elger CE, Bauer J, Scherrmann J, Widman G.
    Epilepsia; 1998 Mar 01; 39 Suppl 3():S15-8. PubMed ID: 9593231
    [Abstract] [Full Text] [Related]

  • 50. Incontinence during treatment with gabapentin.
    Gil-Nagel A, Gapany S, Blesi K, Villanueva N, Bergen D.
    Neurology; 1997 May 01; 48(5):1467-8. PubMed ID: 9153498
    [No Abstract] [Full Text] [Related]

  • 51. [Gabapentin in children and adolescents with epilepsy].
    Herranz JL.
    Rev Neurol; 1997 May 01; 34(4):384-7. PubMed ID: 12022057
    [Abstract] [Full Text] [Related]

  • 52. Long-term treatment with gabapentin for partial epilepsy.
    Ojemann LM, Wilensky AJ, Temkin NR, Chmelir T, Ricker BA, Wallace J.
    Epilepsy Res; 1992 Nov 01; 13(2):159-65. PubMed ID: 1464301
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Gabapentin.
    Chadwick D.
    Lancet; 1994 Jan 08; 343(8889):89-91. PubMed ID: 7903783
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Efficacy and tolerability of gabapentin in clinical practice.
    Morris GL.
    Clin Ther; 1995 Jan 08; 17(5):891-900. PubMed ID: 8595641
    [Abstract] [Full Text] [Related]

  • 59. Gabapentin withdrawal syndrome.
    Norton JW.
    Clin Neuropharmacol; 2001 Jan 08; 24(4):245-6. PubMed ID: 11479399
    [Abstract] [Full Text] [Related]

  • 60. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine.
    Sethi A, Chandra D, Puri V, Mallika V.
    Neurol India; 2002 Sep 08; 50(3):359-63. PubMed ID: 12391470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.